Kavita Mistry MD PhD

Onconephrologist, Beth Israel Deaconess Medical Center

185 Pilgrim RdBoston, MA 02215
Phone+1 617-632-9880

Dr. Mistry is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mistry's full profile Already have an account?

Summary

Dr. Mistry is a board certified nephrologist and physician-scientist at Beth Israel Deaconess Medical Center sub-specializing in onconephrology, providing kidney care to patients with cancer.

Education & Training

Harvard UniversityPost-doctoral Fellowship, Immunology, 2023 - 2026
Beth Israel Deaconess Medical CenterFellowship, Nephrology, 2022 - 2025
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2019 - 2022
Yale School of MedicineClass of 2019
Yale UniversityPhD, Cellular and Molecular Physiology, 2014 - 2017

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2019 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
Yale University Certificate of College Teaching Preparation

Awards, Honors, & Recognition

AKF Clinical Scientist in Nephrology Award American Kidney Fund, 2024
Yale M.D./Ph.D. Alumni Award Yale School of Medicine, 2019
Yale Prize Teaching Fellowship Award Yale University, 2018

Publications & Presentations

PubMed

2 citations
Spatial Transcriptomics Identify T Cell-Driven Mechanisms of Kidney Damage in Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis.
Qian Qin, Lennard Ostendorf, Sophia L Wells, Ce Gao, Miles Tran
Biorxiv. 2025-11-03
1 citations
Comparative safety of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in patients receiving anti-neoplastic therapies for cancer: An i...
Jiaxuan Lyu, Katherine Specht, Jacqueline A Seiglie, Tianqi Ouyang, Kavita Mistry
Cancer Letters. 2025-11-01
7 citations
Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis.
Shruti Gupta, Kavita Mistry, Firasat M Alikhan, Sherley M Mejia, Sagar Sadarangani
Kidney International. 2025-09-01

Journal Articles

Novel biomarkers and imaging tests for AKI diagnosis in patients with cancer.
Kavita Mistry, Sagar Sadarangani, Daiana Moreno, Sherley M. Mejia, Dennis G. Moledina, Meghan E. Sise, Kidney 360., 1/2025
Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma.
Kavita Mistry, Sophia Zhao, Ian Strohbehn, Qiyu Wang, Paul Hanna, Meghan E. Sise, Nephrology, Dialysis, Transplantation, 5/31/2024
Immunological mechanisms underlying clinical phenotypes and noninvasive diagnosis of immune checkpoint inhibitor-induced kidney disease.
Harish Seethapathy, Kavita Mistry, Meghan E Sise, Immunological Reviews, 9/1/2023

Abstracts/Posters

An Atypical Case of Lysozyme-Induced Nephropathy
Greis, W., Kavcar, A., Morales, A., Seng, N., William, J. H., Venkataraman, S., Rosen, S., Mistry, K., Lecker, S. H., National Kidney Foundation Spring Clinical Meeting 2025, Boston, MA, 4/8/2025
Trial of Steroids for MPN-Associated Glomerulopathy: A Case Report
Mistry, K., Dale, L., Rosen, S., Lecker, S. H., National Kidney Foundation Spring Clinical Meeting 2025, Boston, MA, 4/8/2025
Angiomotin is a Novel Interaction Partner of the Polycystin-1 C-terminal Tail
Mistry, K, Gresko, N, Caplan, MJ., American Society of Nephrology Kidney Week 2017 Annual Meeting, New Orleans, LA

Lectures

scRNAseq Reveals Conserved T Cell Populations Detected across Kidney Tissue and Urine of Patients with Immune Checkpoint Inhibitor-Associated Nephritis
Arthur and Sandra Irving Cancer Immunology Innovation Retreat, Falmouth, MA - 4/15/2025
Onco-ICU: complex oncology care at the crossroads of intensive care
National Kidney Foundation Spring Clinical Meeting Pre-Course, Boston, MA - 4/9/2025
Onco-electrolytes
National Kidney Foundation Spring Clinical Meeting Pre-Course, Boston, MA - 4/8/2025

Press Mentions

American Kidney Fund awards Clinical Science in Nephrology fellowships to researchersApril 18th, 2024
American Kidney Fund Awards Fellowships to Researchers Studying Acute Interstitial Nephritis and Pulmonary Hypertension in Kidney PatientsApril 11th, 2024

Grant Support

Clinical Scientist in Nephrology AwardAmerican Kidney Fund2024–2026
Ruth L. Kirschstein NRSA Individual Predoctoral MD/PhD Fellowship (F30)NIH/NHLBI2016–2019

Committees

Fellow Intern, Continuous Professional Development Committee, American Society of Nephrology 2024 - Present
Member, Brigham and Women's Hospital Clinico-pathologic Conference Committee 2021 - 2022
Member, Brigham and Women's Hospital Junior Humanistic Curriculum Committee 2021 - 2022
Student Member, Yale School of Medicine Admissions Committee 2016 - 2017

Research History

Post-doctoral FellowshipSingle-cell RNA sequencing of biospecimens from patients with immune checkpoint inhibitor-associated nephritis2023 - 2025
Pre-doctoral FellowshipThesis Entitled: Mistry, K. Explorations in Autosomal Dominant Polycystic Kidney Disease: Novel Effectors of Polycystin-1 Function. New Haven (CT): Yale University; 20182014 - 2018